Cite

HARVARD Citation

    Lankadeva, Y. et al. (2021). Emerging benefits and drawbacks of α2‐adrenoceptor agonists in the management of sepsis and critical illness. British journal of pharmacology. pp. 1407-1425. [Online]. 
  
Back to record